diabetic macular edema

Novartis raises the temp on Eylea rivalry with head-to-head trial win for Beovu in diabetic macular edema
Endpoints
Tue, 12/15/20 - 10:51 am
Regeneron
Eylea
Novartis
Beovu
diabetic macular edema
Novartis says Beovu matched rival Eylea in visual acuity in eye disease
Pharma Live
Mon, 09/14/20 - 10:41 am
Novartis
Beovu
Eylea
Regeneron
diabetic macular edema
clinical trials
Merck passes on KalVista DME candidate
Seeking Alpha
Tue, 02/11/20 - 10:44 am
Merck
KalVista
diabetic macular edema
KVD001
KalVista's diabetic macular edema data falls short — will Merck walk away?
Endpoints
Mon, 12/9/19 - 09:58 am
KalVista
Merck
diabetic macular edema
KVD001
Where now for Oxurion?
EP Vantage
Wed, 08/21/19 - 09:28 am
Oxurion
THR-149
diabetic macular edema
Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes
Medical Devices and Diagnostics Industry
Sat, 04/6/19 - 01:47 pm
eye health
artificial intelligence
Roche
Genentech
diabetic macular edema
Roche Study Shows AI Can Detect Severity of Diabetic Macular Edema
BioSpace
Thu, 03/7/19 - 09:56 am
artificial intelligence
Roche
Genentech
telemedicine
diabetic macular edema
devices
Opthea Reports Positive Data from Ph Ib Study for Diabetic Macular Edema Drug
CP Wire
Fri, 10/26/18 - 11:50 am
Opthea
OPT-302
diabetic macular edema
Opthea Reports Positive Data from Ph Ib Study for Diabetic Macular Edema Drug
Fri, 10/26/18 - 09:52 am
Opthea
OPT-302
diabetic macular edema
Allegro Appoints New CEO and Prepares for Ph III Trials for Diabetic Macular Edema Drug
CP Wire
Tue, 08/21/18 - 10:12 am
Allegro
Luminate
diabetic macular edema
clinical trials
diabetes
Allegro Appoints New CEO and Prepares for Ph III Trials for Diabetic Macular Edema Drug
Tue, 08/21/18 - 09:55 am
Allegro
Luminate
diabetic macular edema
Mylan, Momenta take aim at Regeneron’s Eylea with biosimilar
Drug Delivery Business News
Thu, 01/4/18 - 11:01 am
Mylan Labs
Momenta Pharmaceuticals
Regeneron
Eylea
biosimilars
diabetic macular edema
wet age-related macular degeneration
M710
Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal
Endpoints
Tue, 10/10/17 - 09:50 am
Merck
KalVista
KVD001
diabetic macular edema
Allegro’s diabetic macular edema trial meets primary endpoint
Drug Delivery Business News
Wed, 08/9/17 - 11:17 pm
Allegro
diabetic macular edema
clinical trials
Luminate
Regeneron Beats Genentech In Rare Face Off Over Diabetes-Related Vision Loss
Forbes
Thu, 02/19/15 - 10:38 am
Regeneron
Genentech
diabetes
Eylea
Lucentis
DME
diabetic macular edema
Roche's blockbuster Lucentis nabs fourth FDA approval
BioPharma Dive
Mon, 02/9/15 - 06:01 pm
Roche
Lucentis
FDA
DME
diabetic macular edema
Regeneron's Eylea works better vs Avastin and Lucentis in study
Yahoo/Reuters
Fri, 10/17/14 - 09:50 am
Regeneron
Eylea
Avastin
Lucentis
diabetic macular edema
Fourth time's the charm: pSivida, Alimera jump on FDA nod for Iluvien
Mass Device
Mon, 09/29/14 - 01:55 pm
pSivida
Alimera
FDA
devices
Iluvien
diabetic macular edema
Alimera's eye implant Iluvien wins FDA approval
Yahoo/Reuters
Sat, 09/27/14 - 09:33 am
Alimera
Iluvien
pSivida
diabetic macular edema
FDA OKs expanded use of Regeneron's eye drug
Yahoo/Reuters
Tue, 07/29/14 - 07:35 pm
FDA
Regeneron
Eylea
diabetic macular edema

Pages